Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ).
Shanghai Junshi Biosciences Co., Ltd. has announced the closure of its register of members of H shares from September 22 to September 26, 2025. This closure is to determine the entitlements of shareholders to attend and vote at the company’s first extraordinary general meeting on September 26, 2025, impacting shareholder participation and decision-making processes.
The most recent analyst rating on (HK:1877) stock is a Sell with a HK$18.00 price target. To see the full list of analyst forecasts on Shanghai Junshi Biosciences Co., Ltd. Class H stock, see the HK:1877 Stock Forecast page.
More about Shanghai Junshi Biosciences Co., Ltd. Class H
Shanghai Junshi Biosciences Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biosciences industry. The company is involved in the development and commercialization of innovative drugs, focusing on providing advanced medical solutions.
Average Trading Volume: 13,577,005
Technical Sentiment Signal: Buy
Current Market Cap: HK$45.42B
For an in-depth examination of 1877 stock, go to TipRanks’ Overview page.